These results pinpoint that TRIO affects the translocation of β-catenin in nuclear, thereby regulating the activation of lung fibroblasts and suggest that miR-29b blocks EMT and lung fibroblast activation in IPF by targeting TRIOBP regulation of TRIO. The gene discussed is TRIOBP; the disease is idiopathic pulmonary fibrosis.